The impact of co-morbid personality disorder on use of psychiatric services and involuntary hospitalization in people with severe mental illness by Fok, Marcella Lei Yee et al.
                          Fok, M. L. Y., Stewart, R., Hayes, R. D., & Moran, P. (2014). The impact of
co-morbid personality disorder on use of psychiatric services and involuntary
hospitalization in people with severe mental illness. Social Psychiatry and
Psychiatric Epidemiology, 49(10), 1631-1640. 10.1007/s00127-014-0874-4
Peer reviewed version
Link to published version (if available):
10.1007/s00127-014-0874-4
Link to publication record in Explore Bristol Research
PDF-document
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
Take down policy
Explore Bristol Research is a digital archive and the intention is that deposited content should not be
removed. However, if you believe that this version of the work breaches copyright law please contact
open-access@bristol.ac.uk and include the following information in your message:
• Your contact details
• Bibliographic details for the item, including a URL
• An outline of the nature of the complaint
On receipt of your message the Open Access Team will immediately investigate your claim, make an
initial judgement of the validity of the claim and, where appropriate, withdraw the item in question
from public view.
1 
 
The impact of co-morbid personality disorder on use of psychiatric services and 
involuntary hospitalization in people with severe mental illness 
 
King's College London, King's Health Partners, Dept of Health Service and Population Research, 
Institute of Psychiatry, London, UK 
Marcella Lei-Yee Fok, MRCPsych 
Robert Stewart, MD 
Richard D Hayes, PhD* 
Paul Moran, MD* 
 
*Joint senior authors 
Corresponding author: Paul Moran, Institute of Psychiatry, Box PO28, De Crespigny Park, London, 
UK, SE5 8AF. Email: paul.moran@kcl.ac.uk  Tel: 020 7848 0568   Fax: 020 7848 5056 
 
 
 
 
 
Abstract length: 250 words 
Manuscript length: 3887 words 
2 
 
ABSTRACT 
Purpose: 
To examine the impact of co-morbid personality disorder (PD), on inpatient and community-based 
service use and risk of involuntary hospitalization, amongst patients with severe mental illness (SMI). 
Methods: 
We identified SMI cases (schizophrenia, schizoaffective and bipolar disorder) with and without co-
morbid PD, and PD cases, aged ≥18 years, in a large secondary mental healthcare case register. Using 
multivariable logistic regression, we examined the association between co-morbid PD and high level 
of inpatient and community-based service use (defined as the top decile of service use), and 
involuntary hospitalization, respectively, adjusting for socio-demographics, clinical symptoms and 
social functioning. 
Results: 
SMI patients with co-morbid PD (SMI-PD) (n=961) had more severe symptoms and social 
functioning problems compared to SMI patients without PD (n=10,963) and patients who had PD but 
no concurrent SMI (n=2,309). A greater proportion of SMI-PD patients were high inpatient service 
users (22.4% vs. 10.1%). This association was attenuated but remained significant, after adjustment 
(fully adjusted odds ratio, OR: 2.31, 95% CI 1.88 – 2.84). The association between SMI-PD and high 
community-based service use was confounded by symptoms and social functioning. Compared to 
patients with SMI, SMI-PD patients were significantly more likely to experience involuntary 
hospitalization (fully adjusted OR 1.56, 95% CI 1.31 – 1.85). 
Conclusions: 
In SMI patients, co-morbidity with PD is robustly associated with both high use of inpatient 
psychiatric services and an increased likelihood of involuntary hospitalization.  Patients with SMI and 
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co-morbid PD are likely to require tailored interventions that target both the underlying personality 
pathology as well as the Axis I disorder. 
Keywords: Personality disorders, severe mental illness, co-morbidity, health services, 
involuntary hospitalization 
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INTRODUCTION 
Personality disorder (PD) is prevalent among patients with severe mental illness (SMI) [1] where it 
has been shown to be independently associated with both suicidal [2] and violent behaviour [3]. 
Moreover people with PD are more likely to report poor physical health [4] and are at substantially 
increased risk of mortality compared to the general population [5]. From a service perspective, studies 
of cohorts of patients with SMI have found that those with co-morbid PD spend more time in hospital 
[6][7].  However, the full impact of co-morbid PD on community and hospital-based service 
utilization by patients with SMI has not been described. Moreover, the factors underlying an 
association between co-morbid PD and increased service use in patients with SMI are not well 
understood. Apart from diagnosis [8], heavy service use amongst people with mental disorder is 
associated with alcohol and drug use, non-adherence with medication [9], homelessness and other 
socio-demographic variables [10], as well as violence [11]. Some or all of these variables may 
confound or mediate an association between co-morbid PD and heavy service use in SMI, but no 
study has examined the impact of controlling for these covariates. 
In this study we used a large historic cohort to examine the impact of co-morbid PD on the use of 
psychiatric services among patients with SMI. For comprehensiveness, we measured both inpatient 
and community-based service use, and took into account a range of socio-demographic, clinical and 
social functioning variables.  SMI predominates amongst patients who are involuntarily hospitalized 
[12]. Given that involuntary hospitalization is associated with level of inpatient service use and has an 
important bearing on clinical outcomes [13], a further objective of this study was to determine 
whether co-morbid PD is associated with increased involuntary hospitalization amongst patients with 
SMI – an association which has also not previously been examined.  
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METHODS 
Setting  
The study was based in South London and Maudsley NHS Foundation Trust (SLaM), a state-funded, 
secondary mental healthcare provider with close to 100% monopoly in serving an aggregate 
population of 1.2 million people living in four London boroughs (Lambeth, Southwark, Lewisham 
and Croydon).  SLaM services include inpatient and community-based care, as well as psychiatric 
liaison services to general hospitals, and forensic, old age, child and adolescent, addictions, and 
learning disability mental health teams. The SLaM Biomedical Research Centre (BRC) Case Register 
provides anonymised in-depth information derived from SLaM’s electronic clinical record system.  
The development and protocol of this case register has been described in detail in a previous open 
access publication [14], and the case register has been used extensively in previous research [15][16]. 
Electronic clinical records have been used comprehensively across all SLaM services since 2006 and 
the BRC Clinical Record Interactive Search (CRIS) system was developed in 2008 to allow searching 
and retrieval of anonymised information from full clinical records with over 200,000 cases currently 
represented on the system. CRIS was approved as a data resource for secondary analysis by the 
Oxfordshire Research Ethics Committee (reference 08/H0606/71).  
Sample 
The cohort assembled for this study consisted of individuals from three mutually exclusive diagnostic 
groups – (1) SMI; (2) PD; and (3) SMI co-morbid with PD (SMI-PD). Diagnoses were based on the 
10th edition of the World Health Organisation International Classification of Diseases (ICD-10) [17]. 
Patients were considered to have SMI if they had been given a lifetime diagnosis of schizophrenia 
(ICD-10 code: F20), schizoaffective disorder (F25) or bipolar affective disorder (F31) at any time 
before the end of the study period. Patients with PD had a lifetime diagnosis of any of the ICD-10 
categories of PD diagnosis (F60.0- F61.0). Individuals were classified as having SMI and PD co-
morbidly if they had been given both an SMI diagnosis and a PD diagnosis during the study period.  
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Diagnoses were taken from a structured field in the Case Register and supplemented by the 
appearance of diagnoses in free text, extracted using Generalised Architecture for Text Engineering 
(GATE) software [18].  
All individuals aged 18 or over within the case register that had been given diagnoses falling in any of 
these groups, and had received SLaM services within the five-year study period from 1 January 2007 
to 31 December 2011, were included. The beginning of 2007 was chosen as a starting point for the 
study because this corresponded to the most complete recording of clinical data on the Case Register. 
Individuals diagnosed with an organic disorder or with mental retardation, within the observation 
period, were excluded from the study. We also excluded from the SMI-PD group any individuals with 
paranoid or schizoid PD (n=74), as these diagnoses should not be made in the presence of a primary 
psychotic diagnosis such as schizophrenia.   
In order to examine the validity of the PD diagnoses in the Case Register, 50 cases with or without a 
PD diagnosis were randomly selected from our cohort. Case note documents for the 50 individuals 
were then independently processed to mask all diagnosis information.  These 50 cases were 
subsequently rated by a trained psychiatrist (MF; who was blind to the original diagnostic information) 
for the presence or absence of PD. The kappa coefficient for level of agreement between the case 
register diagnosis and blind clinical rating of the case records was 0.72 (p<0.001).  
Main outcome measures 
Measures of each individual’s mental health service use with respect to hospitalization, community-
based contact, and involuntary hospitalization were determined by selective and systematic data 
extraction from the case register. For each patient, the observation period began on the 1st January 
2007 or the dates of their first recorded event on the case register from that day onwards, whichever 
was later. Observation ended on 31st December 2011 or the date of death, whichever was earlier.  
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Inpatient service use. The time in days that each individual had spent hospitalized as an inpatient 
was calculated, as a proportion of the duration of his/her observation period.  Patients ranking in the 
top decile on this measure were considered to be high users of inpatient services.  
Community-based service use. Community-based contact was defined as a clinical event in which 
the patient had face-to-face contact with a healthcare worker in any SLaM service other than inpatient 
units. The time in days in which each individual had community-based contact (i.e. count of each day 
in which there was contact) was calculated, as a proportion of the duration of his/her observation 
period. Patients ranking in the top decile on this measure were considered to be high users of 
community-based services.  
Involuntary hospitalization. The Mental Health Act provides the legislative framework by which 
people in England and Wales diagnosed with mental disorder can be detained in hospital or police 
custody and be assessed and treated with respect to their disorder, against their wishes. Use of the 
Mental Health Act is routinely recorded on the case register. Thus, for each patient in the cohort we 
were able to ascertain whether he/she had been involuntarily hospitalized at any point within the 
observation period. This was used as a dichotomous outcome (detained vs. not detained) in the 
analysis.  
Explanatory variables 
Demographic and socioeconomic factors. 
 Date or birth, gender, ethnicity, relationship status, and employment status were defined from 
routinely completed fields on the source records. Age was calculated from the beginning of the 
patient’s observation period. Ethnicity classifications were: “White British or other white 
background”, “East Asian”, “South Asian”, “African, Caribbean or other black background”, and 
“Mixed, unknown, and others”. Relationship status was classified as being in a current relationship 
(cohabiting, married or civil partner) or no current relationship (divorced, civil partnership dissolved, 
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separated, single, widow/surviving civil partner or unknown). Employment status was classified as 
being in paid employment (part-time or full-time paid employment, self employed), or not in paid 
employment (unemployed, registered disabled, retired, full-time student including tertiary or school 
age, government training scheme, volunteer, not known, other).  
We used an area-level index of multiple deprivation to measure socioeconomic status, calculated at 
the level of lower super output area for the residence (LSOA) -- a UK address-grouping construct 
which contains an average of 1,500 residents. The patient’s address in England that was recorded 
closest in time to the beginning of the observation period was used to obtain deprivation scores.  The 
index of multiple deprivation is derived from a range of domains applied to the area including: 
employment, income, education, health, barriers to housing and services, crime and the living 
environment. Each domain is given a specific weighting to reflect its overall importance in the 
calculation of this index. Moreover, each domain is made up of a number of specific indicators that 
reflect different aspects of the deprivation they are intended to measure. Increasing scores in the index 
of multiple deprivation are indicative of more severe deprivation. In this analysis, deprivation scores 
were divided into tertiles. A separate category was given for homelessness. 
 
Symptoms and social functioning.  
We rated for the presence and severity of symptoms, as well as social functioning problems using the  
Health of the Nations Outcome Scale (HoNOS), a well-validated, 12-item, clinician-administered 
measure [19][20][21]. Eight of the 12 items assess clinical symptoms– (1) overactive, aggressive, 
disruptive or agitated behaviour; (2) non-accidental self-injury; (3) problem-drinking or drug-taking; 
(4) cognitive problems; (5) physical illness or disability problems; (6) problems associated with 
hallucinations and delusions; (7) problems with depressed mood; (8) other mental and behavioural 
problems. The remaining four items cover social functioning – (9) problems with relationships; (10) 
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problems with activities of daily living; (11) problems with living conditions; (12) problems with 
occupation and activities. The 12 items have operationalized response options that follow the format 
of 0 “not a problem”; 1 “subclinical, minor problem requiring no action”,  2 “mild problem but 
definitely present”, 3 “ moderately severe problem”, and 4 “severe to very severe problem” [22]. In 
this analysis we used items from the first HoNOS questionnaire that was completed during the 
observation period as measures of baseline level of symptoms and social functioning in each patient. 
Due to small numbers in some categories, for the purposes of data analysis, all HoNOS items were 
collapsed into two categories: 0-2) not a problem, subclinical, or mild problem, and 3-4) severe or 
very severe problem. Overall, 79.7% of patients in the study received at least one HoNOS assessment 
during the observation period. Due to incomplete data for some covariates, the final fully-adjusted 
models had analytic samples that were reduced compared to the crude models. However, incomplete 
data were evenly distributed between the exposure groups. 
 
Statistical analysis 
All analyses were undertaken using STATA 11 [23].  We used multivariate logistic regression to 
model the effect of different diagnosis categories on the three outcomes (inpatient service use, 
community-based service use, and involuntary hospitalization), adjusting for possible explanatory 
variables. We present crude and adjusted odds ratios with 95% confidence intervals derived from 
logistic regression models. In all three cases, the first logistic regression model included only 
diagnosis as an explanatory variable. The second model also included demographic factors (age, 
gender, ethnicity, relationship status) and socioeconomic factors (deprivation in area of residence and 
employment) were subsequently added to the model. In the third and final model of predictors of 
service use, we added symptoms and social functioning as covariates to the model. In modelling 
predictors of involuntary hospitalization, we also adjusted for length of observation period.  
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We conducted two sets of sensitivity analyses. The first set involved using 5% and 15% as alternative 
definitions to the original top 10% cut-off for defining high inpatient and community-based service 
use. The second set of sensitivity analyses used inpatient and community-based service use as 
continuous variables, and modelled these using linear regressions.  The service use data were highly 
skewed and, therefore, we log-transformed these data (resulting in the data approximating a normal 
distribution) before developing the two linear regression models.  
RESULTS 
A total of 14233 individuals were identified by CRIS, using our criteria for inclusion into the study. 
The cohort was 54.3% male and had a mean age of 41.9 years (standard deviation 14.7 years).  In 
terms of ethnic background, 53.8% were white, 30.4% were African, Caribbean or other black 
background, 2.9% were East Asian, 2.6% were South Asian, and 10.3% were mixed or unknown. 
Twelve per cent of the cohort had a cohabiting, married or in a civil partnership relationship status 
and 2.4% of the cohort was classified as homeless. Only 4.2% of the cohort were in paid employment. 
5.9% of the cohort died before the end of the study observation period (31st December 2011). 
Of the 14233 individuals, 10963 were in the SMI group, 2309 in the PD group, and 961 in the SMI-
PD group. Table 1 provides the demographic and socioeconomic characteristics of the patients 
included in the study, according to the three diagnosis groups. Compared to the SMI group, a larger 
proportion of the SMI-PD group was younger, from a white ethnic background and was homeless and 
a smaller proportion was in a relationship. 
Differences were noted in the HoNOS sub-scale profiles between the SMI and SMI-PD groups. 
Compared to the SMI group, the SMI-PD group had a higher proportion of individuals with severe or 
very severe problems in five of eight symptom domains - overactivity and aggression (13.5% vs 6.8%; 
p<0.001); non-accidental injury (8.3% vs 1.7%; p<0.001); depressed mood (13.7% vs 6.5%; p<0.001); 
problem drinking or drug-taking (16.3% vs 6.2%; p<0.001); other mental health problem (23.7% vs 
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14.3%; p<0.001). They also had a greater proportion of individuals with severe problems compared to 
the SMI group, in three of four social functioning domains – occupational (14.2% vs 9.3%; p<0.001); 
living conditions (11.5% vs 6.9%; p<0.001); and relationship problem (19.7% vs 10.3%; p<0.001). In 
the remaining three clinical domains (hallucinations and delusions, cognitive problems, physical 
illness or disability) and one social functioning domain (activities of daily living) the two groups were 
comparable. 
Table 2 shows the measures of psychiatric service use amongst the three diagnosis groups. Five 
thousand six hundred and eight individuals (39.4% of total cohort) had at least one inpatient 
admission during the study period. The PD group had proportionately fewer patients (26.9%), and the 
SMI-PD group had proportionately more patients (63.1%) admitted as an inpatient, compared to the 
SMI group (40.0%). Those in the top 10 percent of inpatient service use (as a proportion of length of 
observation period) spent an average of 136.4 days per year in hospital. Amongst the three diagnosis 
groups, the SMI-PD group had the highest proportions of high users of inpatient services (22.4%) and 
high users of community-based services (13.6%) respectively. This group also had the highest 
prevalence of individuals experiencing involuntary hospitalization (41.8%). In contrast, the PD group 
had the lowest proportions of high users of both inpatient (4.5%) and community-based (5.4%) 
services, as well as involuntary hospitalization (10.7%). 
Table 3 displays the results of multivariate logistic regression for high inpatient service use. 
Individuals with SMI and co-morbid PD were twice as likely to be high users of inpatient services 
compared to individuals with SMI without co-morbid PD (crude odds ratio 2.57, 95% confidence 
interval 2.18 – 3.03, p value<0.001). Adjustment for demographic and socioeconomic factors did not 
attenuate the association and addition of baseline severity of symptoms and social functioning 
problems to the model had little impact on the strength of the association (fully adjusted odds ratio 
2.31, 95% confidence interval 1.88 – 2.84, p value<0.001).  
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The equivalent regression model for high community-based service use is shown in Table 4. Co-
morbid PD conferred a small but significant increase in the odds of high service use (crude odds ratio 
1.32, 95% confidence interval 1.09 – 1.61, p value<0.05). This association was not attenuated by 
adjustment for demographic and socioeconomic factors. However, the addition of clinical and social 
functioning problems to the model rendered the odds ratio non significant (fully adjusted odds ratio 
1.11, 95% confidence interval 0.89 – 1.39). 
Sensitivity analysis using the top 5% as cut-off for high service use yielded similar results (adjusted 
odds ratio (AOR) for inpatient service use associated with co-morbid PD: 2.75, 95% confidence 
interval 2.11-3.58; AOR for community-based service use: 0.96, 95% confidence interval 0.75-1.21); 
likewise, when using 15% as alternative cut-off (AOR for inpatient service use: 1.98, 95% confidence 
interval 1.64-2.38; AOR for community-based service use 1.08, 95% confidence interval 0.89-1.30).. 
When we re-ran the analyses using linear regression, the independent effect of co-morbid PD on the 
inpatient service use of SMI patients was retained (fully adjusted β coefficient 0.28, 95% confidence 
interval 0.14 – 0.41, p value<0.001). The sensitivity analysis for community-based service use 
showed a smaller but independent effect of co-morbid PD (fully adjusted β coefficient 0.16, 95% 
confidence interval 0.07 – 0.26, p value<0.01). 
Table 5 shows the multivariate regression for involuntary hospitalization. SMI patients with co-
morbid PD were almost twice as likely to be involuntarily hospitalized compared to SMI patients 
without co-morbid PD (crude odds ratio 1.83, 95% confidence interval 1.60 – 2.09, p value<0.001). 
Adjustment for demographic and socioeconomic factors, symptoms and social functioning, and length 
of observation period in the study, did not attenuate this association (fully adjusted odds ratio 1.56, 
95% confidence interval 1.31 – 1.85, p value< 0.001).  
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DISCUSSION 
Main Findings 
In this cohort of patients accessing secondary mental health services, SMI patients who had co-morbid 
PD were significantly more likely to be high users of inpatient services, compared to SMI patients 
without co-morbid PD. This association remained significant after adjustment for socio-demographic 
factors and a wide range of clinical and social functioning variables. The presence of co-morbid PD 
also significantly increased the likelihood of involuntary hospitalization among SMI patients, an 
association which was not explained by the measured potential confounding variables.  
Previous Work and possible mechanisms 
To the best of our knowledge this is the first study to examine the impact of co-morbid PD on both 
inpatient and community-based service use of adult patients with SMI. Tyrer and Simmonds [7] 
reviewed the outcome of three randomised controlled trials that investigated different models of care 
in SMI, and found in post-hoc analyses that patients with co-morbid PD spent more time in hospital 
compared to those without co-morbid PD, regardless of the model of care. Keown and others 
investigated psychiatric bed use amongst SMI patients seen in a UK community mental health team, 
and found that the concurrent presence of PD and also severity of PD were associated with increased 
psychiatric bed use amongst SMI patients [7][6]. Our finding that co-morbid PD increases inpatient 
service use in SMI patients is consistent with  existing evidence that co-morbid personality pathology 
worsens outcomes in SMI [24][25][26][2][3][27].  The SMI-PD patient group in our study was 
characterised by a number of factors known to contribute to increased psychiatric service use -- more 
severe psychopathology [25], higher levels of aggression [11] and self-injury [28], greater problems 
with alcohol and drug use [29][30], greater problems with housing [11] and occupation, and less 
stable relationships [31][32], compared to the SMI group. However, adjustment for these potential 
confounders had little effect on the strength of the association with inpatient service use.  
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Based on previous work on patients with PD and co-morbid PD [33][34], one may have expected a 
similar pattern with regard to community-based services.  However we did not detect an association 
between co-morbid PD and community-based service use. While we would not expect high inpatient 
use to exclude high community service use, it may be that some patients had their clinical needs met 
as an inpatient rather than in the community. Indeed, some individuals in the top decile of inpatient 
service use spent a great majority of the year in hospital, consequently reducing the amount of time 
that they could have received community services.  Although we know of no other study that has 
examined both inpatient and community-based service use in adults with a dual diagnosis of SMI and 
PD, a recent study in adolescents with Axis I psychiatric disorders [35] found that those with co-
morbid PD used more inpatient and emergency, but comparable outpatient, psychiatric services, 
compared to those without co-morbid PD.  
No study has previously examined the impact of co-morbidity with PD on the risk of involuntary 
hospitalization in patients with SMI. The combination of personality disorder in the presence of SMI 
independently increased the risk of involuntary hospitalization.  Compared to the SMI group, the 
SMI-PD group had a higher proportion of individuals with severe clinical problems in five of eight 
clinical domains, including aggression [36]  and non-accidental injury.  Levels of social dysfunction 
were also higher among the SMI-PD group compared to the SMI group. Thus factors associated with 
increased risk to self and/or others (a criterion for involuntary detention under the English Mental 
Health Act) were more prevalent in the SMI-PD group compared to those with SMI alone.  These 
factors are very likely to be on the causal pathway to involuntary hospitalization for those with co-
morbid PD and the attenuation in the size of the odds ratio which occurred when these covariates were 
added to the model provides some support for this argument.  A diagnosis of personality disorder 
alone was associated with a lower likelihood of detention in hospital.  This is consistent with 
recommended clinical practice [37], as there is no evidence base to suggest that compulsory treatment 
in hospital for people with PD improves clinical outcomes.   
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Strengths and Limitations 
The study used a large cohort derived from a secondary mental health setting which included the full 
range of inpatient and community-based services and to our knowledge is the first study of its kind.  
We accounted for a wide range of covariates, including demographic, socioeconomic, clinical and 
social functioning variables. Examining both inpatient admission and all community-based service 
use in the cohort, as well as involuntary hospitalization, offered a fuller and more comprehensive 
picture of the impact of co-morbid PD in patients with SMI and this adds to the novelty of the 
findings. 
The findings need to be considered in the light of certain limitations. We relied on ICD-10 diagnoses 
as opposed to standardised assessments, but the use of routinely-collected clinical data allowed us to 
obtain data on a very large sample size, thus optimising the precision of our findings.  Moreover, our 
use of routine clinical diagnoses in a very large population favours generalisability to real clinical 
practice. In addition, we established an acceptable level of reliability between the case register 
diagnoses of personality disorder and blind clinical ratings.  Although there was incomplete data in 
some models, it is unlikely to explain the observed associations, as there was little variation in results 
across the regression models. In addition, incomplete data was not unevenly distributed among the 
exposure groups of interest (SMI and SMI-PD). Misclassification of area deprivation level may have 
occurred for any cohort members who moved during the course of the study.  There was a wide 
distribution of the time from start of observation to first HoNOS rating in the cohort (median 116 days, 
interquartile range 18 to 357 days) and this may have influenced the results. The relatively low 
prevalence of co-morbid PD in the SMI cohort (8.1%), stands in contrast with prevalence rates 
reported in other studies [38][39][40][41] and indicates that there was under-detection of  PD in our 
sample [24][42]. On the other hand, it is possible that some cases of PD were misclassified and that 
the probability of this occurring was dependent upon service use (i.e. that heavy users of services 
were more likely to attract a diagnosis of PD). If this is the case, then it is possible that we have 
overestimated the strength of association between co-morbid PD and heavy service use.  The 
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historical cohort design means that in some cases, the diagnosis of co-existing PD was made during 
the course of or in some cases, towards the end of the individual’s observation period. This, together 
with our cross-sectional analysis, limits our ability to make causal inferences.  
 
We conclude that amongst patients with SMI, the co-existence of PD is independently associated with 
both high use of inpatient psychiatric services and an increased likelihood of involuntary 
hospitalization. Co-morbid PD is often unrecognised yet, as shown by our data, it is an important 
prognostic variable. This highlights the importance of routinely assessing personality status in 
individuals presenting to secondary mental health services [43] with Axis 1 disorders. Patients with 
SMI and co-morbid PD are likely to require tailored interventions that target both the underlying 
personality pathology as well as the Axis I disorder. In this respect, better treatment models are 
required to help to reduce admissions and involuntary hospitalization for patients with SMI and co-
morbid Axis II pathology [7][41][44].  
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